Laurion Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-89,700
Closed -$25M 248
2025
Q2
$25M Buy
+89,700
New +$25.4M 0.45% 57
2024
Q3
Sell
-6,800
Closed -$2.12M 293
2024
Q2
$2.12M Sell
6,800
-93,600
-93% -$27.5M 0.03% 222
2024
Q1
$28.5M Buy
100,400
+85,400
+569% +$25M 0.24% 89
2023
Q4
$4.32M Hold
15,000
0.04% 254
2023
Q3
$4.03M Buy
+15,000
New +$3.74M 0.02% 294
2023
Q2
Sell
-250,000
Closed -$60.4M 598
2023
Q1
$60.4M Buy
+250,000
New +$61.4M 0.41% 58
2021
Q1
Sell
-52,300
Closed -$12M 737
2020
Q4
$12M Buy
+52,300
New +$12.1M 0.09% 169
2020
Q3
Sell
-36,500
Closed -$523K 822
2020
Q2
$523K Sell
36,500
-137,300
-79% -$31.3M 0.01% 608
2020
Q1
$35.2M Buy
173,800
+83,500
+92% +$18.2M 0.38% 60
2019
Q4
$21.8M Hold
90,300
0.17% 135
2019
Q3
$17.5M Buy
+90,300
New +$17.3M 0.13% 168
2019
Q2
Sell
-40,000
Closed -$7.6M 881
2019
Q1
$7.6M Sell
40,000
-61,700
-61% -$11.8M 0.1% 156
2018
Q4
$19.8M Buy
+101,700
New +$19.8M 0.35% 58
2018
Q2
Sell
-263,600
Closed -$44.9M 1305
2018
Q1
$44.9M Buy
263,600
+115,800
+78% +$21.3M 0.36% 65
2017
Q4
$25.7M Sell
147,800
-111,000
-43% -$19.6M 0.13% 171
2017
Q3
$48.3M Buy
258,800
+94,200
+57% +$16.7M 0.21% 80
2017
Q2
$28.3M Buy
164,600
+74,600
+83% +$12.1M 0.16% 131
2017
Q1
$14.8M Buy
+90,000
New +$15M 0.11% 218
2016
Q4
Sell
-42,300
Closed -$7.06M 1091
2016
Q3
$7.06M Sell
42,300
-3,000
-7% -$507K 0.07% 277
2016
Q2
$6.89M Buy
+45,300
New +$7.04M 0.11% 214
2016
Q1
Sell
-100,000
Closed -$16.2M 773
2015
Q4
$16.2M Buy
+100,000
New +$15.7M 0.15% 146
2015
Q3
Sell
-340,000
Closed -$52.2M 724
2015
Q2
$52.2M Buy
+340,000
New +$54.5M 0.48% 51
2013
Q3
Sell
-134,300
Closed -$13.3M 174
2013
Q2
$13.3M Buy
+134,300
New +$13.9M 0.82% 33

Other funds holding AMGN

Laurion Capital Management's AMGN Position: Q1 2026 in Review

Laurion Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 3,000 shares — an estimated $982K sold.

Laurion Capital Management first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $19.7M in Q3 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Laurion Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 3,000 Amgen shares in Q1 2026, an estimated $982K.
  • Laurion Capital Management first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
  • Laurion Capital Management's Amgen position peaked at $19.7M in Q3 2014.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.